Themes

Cocrystal receives approval from HREC for Phase I trial of Covid-19 therapy

CDI-988 demonstrated in vitro potency against SARS-CoV-2 and other coronaviruses.

Artificial Intelligence

View More

Cloud

View More

Corporate Governance

View More

Cybersecurity

View More

Environmental Sustainability

View More

Internet of Things

View More

Robotics

View More

Social Responsibility

View More

Covid-19

View More